Lv2
171 积分 2025-02-12 加入
TRI-611, a selective, brain-penetrant molecular glue degrader of ALK
12天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
30天前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
30天前
已完结
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
1个月前
已完结
Recipient Endothelial IRF1 mediates IFNγ-driven tissue tolerance in mouse models of acute Graft-versus-Host Disease
1个月前
已关闭
Discovery and Optimization of a WRN Helicase Inhibitor Series through Structure-Guided Drug Design from a Covalent Fragment Binding Insight
1个月前
已完结
Bruton tyrosine kinase inhibitors for multiple sclerosis
2个月前
已完结
Re-defining progression in multiple sclerosis
2个月前
已完结
From covalent to reversible: the expanding role of BTK inhibitors in chronic lymphocytic leukemia
2个月前
已完结
The preclinical discovery and development of acalabrutinib for the treatment of mantle cell lymphoma
2个月前
已完结
皖公网安备34019202002308
